Daily Dilution Report - Apr 14, 2026
All Events
$PPIH (MC: $283M)
- Filing does not contain any stock dilution events.
- Details new Credit Agreement (debt financing).
- No new equity issuance, debt to equity conversion, or option/warrant exercise.
$RPAY (MC: $272M)
- Stockholder Rights Plan (Poison Pill) adopted to deter hostile takeovers.
- Potential dilution if triggered: Rights allow purchase of Common Stock (market value $34.00) for $17.00.
- Each Right allows purchase of 1/1000th Series A Preferred Stock for $17.00, equivalent to 1 share Common Stock.
$TBN (MC: $845M)
- Underwriters' Over-allotment Option: 3.4M potential shares if exercised.
- Filing for fees related to option; specific terms (exercise price, expiration) not provided.
$AVNS (MC: $676M)
- This filing describes the cancellation of existing equity awards (RSUs and options) in exchange for cash consideration as part of the merger. It also mentions the financing for the merger via an Equity Commitment Letter from American Industrial Partners Capital Fund VIII, L.P.
- Crucially, this filing does not describe any new issuance of stock or securities that would result in stock dilution in the traditional sense (like new warrants, convertible notes, ATM programs, etc.). The existing equity awards are being cashed out, not converted into new dilutive instruments.
$SAFX (MC: $244M)
- Proposed business combination with DevvStream & Southern Energy Renewables.
- Future dilution from existing DevvStream Warrants, Options, RSUs, and Convertible Notes converting into SAFX common shares upon merger close.
- Specific terms (share count, prices) for these DevvStream instruments are not detailed in this filing.
$SANA (MC: $857M)
- Direct Offering to Mayo Clinic: 15.01M shares at $3.33/share for $50M (Initial close expected April 15, 2026).
- Pre-funded Warrants: 9.77M shares issuable at $0.0001/share.
- Potential future dilution from options, RSUs, and reserved plans totals ~74.9M shares.
$ALLO (MC: $746M)
- Underwritten Offering & Over-allotment Option: Up to $201.25M common stock (shares not specified).
- ATM Offerings: 12.48M common shares issued at $1.68/share subsequent to Dec 31, 2025.
- Equity Plans: ~88M shares authorized/reserved for future issuance from stock options, RSUs, and 2018 Equity/ESPP plans (includes shares added Jan 1, 2026).
$PMI (MC: $1.5B)
- Convertible Note: $555,555 principal, $490,000 cash received.
- Default conversion price: 75% of 10-day lowest trading price.
- 80,128 origination shares issued with the note.
$PWP (MC: $1.9B)
- Unregistered Sales of Equity Securities: 1,127,529 Class A shares issued for purchase consideration at closing.
- An additional 2,255,058 shares to be issued in three annual tranches for purchase consideration.
- Contingent consideration may be payable in shares of Common Stock; exact number not yet determined.